DR Reddys (NYSE: RDY) CIO discloses holding 8,712 equity shares

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD reported the initial holdings of Chief Information Officer Bhethanabottla Srinivasa Phanimitra on a Form 3. The filing shows direct ownership of 8,712 Equity Shares after the reported entry. This is a disclosure of existing beneficial ownership rather than a new stock purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BHETHANABOTTLA SRINIVASA PHANIMITRA

Role Chief Information Officer

Type	Security	Shares	Price	Value
holding	Equity Shares	--	--	--

Holdings After Transaction: Equity Shares — 8,712 shares (Direct)

Footnotes (1)

Key Figures

Equity Shares held: 8,712 shares

1 metrics

Equity Shares held 8,712 shares Total shares directly owned after the reported entry

Key Terms

Form 3, Equity Shares, beneficial ownership

3 terms

Form 3 regulatory

"reported the initial holdings of Chief Information Officer on a Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Equity Shares financial

"direct ownership of 8,712 Equity Shares after the reported entry"

Equity shares are units of ownership in a company that give the holder a claim on a portion of its assets and profits, like owning a slice of a business. They matter to investors because their value can rise or fall with the company’s performance and market sentiment, may provide periodic income through dividends, and often carry voting rights that influence how the business is run.

beneficial ownership financial

"This is a disclosure of existing beneficial ownership rather than a new stock purchase"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BHETHANABOTTLA SRINIVASA PHANIMITRA

(Last) (First) (Middle)

405, DIAMOND BLOCK, PRAGATHI NAGAR,

SRI SAIRAM MANOR, KHAIRATABAD

(Street)

HYDERABAD TELANGANA 500045

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Equity Shares	8,712	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ PHANIMITRA B	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the DR REDDYS LABORATORIES (RDY) Form 3 filing show?

The Form 3 shows that the Chief Information Officer, Bhethanabottla Srinivasa Phanimitra, directly holds 8,712 Equity Shares of DR REDDYS LABORATORIES. It is an initial beneficial ownership report, not a record of a new stock trade or option exercise.

Did the RDY Chief Information Officer buy or sell shares in this Form 3?

The filing does not report a specific purchase or sale transaction. Instead, it lists a holding entry showing the officer directly owns 8,712 Equity Shares. Form 3 is used to disclose existing beneficial ownership when an individual becomes a reporting insider.

How many DR REDDYS LABORATORIES (RDY) shares does the insider hold?

The insider is reported as holding 8,712 Equity Shares directly following the reported entry. This number represents the total beneficially owned shares shown in the Form 3 and reflects the insider’s direct equity position in the company at that time.

Does the DR REDDYS (RDY) Form 3 include any derivative securities?

The Form 3 data shows no listed derivative securities such as options or warrants. The only reported position is 8,712 Equity Shares held directly, indicating that, in this filing, the insider’s disclosed interest is limited to common equity.

What is the role of the reporting person in the RDY Form 3 filing?

The reporting person is the company’s Chief Information Officer, classified as an officer but not as a director or 10% owner. The Form 3 simply records this officer’s beneficial ownership of 8,712 Equity Shares as part of regulatory disclosure requirements.